Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical Neurophysiology Practice|July 26, 2026
Effects of transcranial direct current stimulation and mindful walking on directional brain connectivity: An isolated effective coherence analysisKeiichiro Nishida, Naoya Onishi, Yosuke Koshikawa, et al.International Journal of Molecular Sciences|April 12, 2022
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key PathwaysMasaki Kato, Haruhiko Ogata, Hidetoshi Tahara, et al.International Journal of Molecular Sciences|August 12, 2023
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA AnalysisToshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.The International Journal of Neuropsychopharmacology|August 6, 2022
Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment EffectsAran Tajika, Hikaru Hori, Jun-Ichi Iga, et al.Frontiers in Human Neuroscience|August 24, 2019
Pre-stimulus Brain Activity Is Associated With State-Anxiety Changes During Single-Session Transcranial Direct Current StimulationKeiichiro Nishida, Yosuke Koshikawa, Yosuke Morishima, et al.Neuropsychobiology|November 27, 2015
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia PatientsYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.Neuropsychobiology|January 27, 2016
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot TrialYosuke Koshikawa, Yoshiteru Takekita, Masaki Kato, et al.BMC Psychiatry|May 30, 2016
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trialYoshiteru Takekita, Yosuke Koshikawa, Chiara Fabbri, et al.Journal of Affective Disorders|July 19, 2023
Relationship between circulating mitochondrial DNA and microRNA in patients with major depressionHaruhiko Ogata, Koichiro Higasa, Yuki Kageyama, et al.Journal of Psychiatric Research|February 19, 2017
Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCTMasaki Kato, Yoshiteru Takekita, Yosuke Koshikawa, et al.Pageof 4